CLOV · Clover Health Investments, Corp. /De
$4.60
+0.11 (+2.45%)
At close · Aug 14
Market Cap
$2.44B
Shares
531.16M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$20,000,000
as of 2024-05-06
· not restated in filings since 2024-11-08
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2026-06-30 YTD | $0 | 10-Q, filed 2026-08-07 | ||
| 2025-12-31 | $18,298,000 | 10-K, filed 2026-02-27 | ||
| 2024-12-31 | $1,772,000 | 10-K, filed 2026-02-27 | ||
| 2023-12-31 | $0 | 10-K, filed 2026-02-27 | ||
| 2022-12-31 | $0 | 10-K, filed 2025-03-03 | ||
| 2021-12-31 | $147,000 | 10-K, filed 2024-03-14 | ||
Key facts
CIK
1801170
CUSIP
18914F103
13F (30d)
214 filings
214 filers
Visit website
Investor relations